US Patent Issued to IMPERIAL COLLEGE INNOVATIONS, MYRICX PHARMA on May 26 for "Imidazo[1,2-apyridine compounds and their use in therapy" (British, Swiss Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,458, issued on May 26, was assigned to IMPERIAL COLLEGE INNOVATIONS Ltd. (London) and MYRICX PHARMA Ltd. (London).

"Imidazo[1,2-apyridine compounds and their use in therapy" was invented by Edward William Tate (London), Andrew Simon Bell (London), Roger Bonnert (Geneva), Robin Carr (London) and Timothy John Ritchie (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compounds of Formula (I): and related aspects."

The patent was filed on Sept. 17, 2021, under Application No. 18/026,684.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=H...